ArticleACR open rheumatology2023

A Randomized, Double-Blind, Placebo-Controlled Multicenter Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving Pegloticase: 12-Month Findings.

John K Botson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.